| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 60.7% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 51.79 to 68.87 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'Accuracy (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 17.4% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 9.09 to 30.72 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'NPV (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 86.8% Precision (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 77.45 to 92.69 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'PPV (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 63.5% Recall (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 53.88 to 72.08 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'Sensitivity (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 44.4% Specificity (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 24.56 to 66.28 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'Specificity (95%CI)' |
|---|
| Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 54.9% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 46.07 to 63.46 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCMTs against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'Accuracy (95%CI)' |
|---|
| Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 23.2% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 14.81 to 34.40 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCMTs against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'NPV (95%CI)' |
|---|
| Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 96.2% Precision (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 87.25 to 98.96 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCMTs against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'PPV (95%CI)' |
|---|
| Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 49% Recall (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 39.64 to 58.51 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCMTs against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'Sensitivity (95%CI)' |
|---|
| Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 88.9% Specificity (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 67.20 to 96.90 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCMTs against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'Specificity (95%CI)' |
|---|
| Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 22.9% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 16.38 to 31.17 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-culture only against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'Accuracy (95%CI)' |
|---|
| Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 16.1% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 10.41 to 23.98 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-culture only against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'NPV (95%CI)' |
|---|
| Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 100% Precision (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 72.25 to 100.00 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-culture only against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'PPV (95%CI)' |
|---|
| Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 9.62% Recall (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 5.31 to 16.80 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-culture only against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'Sensitivity (95%CI)' |
|---|
| Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 100% Specificity (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 82.41 to 100.00 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-culture only against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'Specificity (95%CI)' |
|---|
| Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 39.3% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 31.13 to 48.21 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-mNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'Accuracy (95%CI)' |
|---|
| Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 14.1% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 8.06 to 23.51 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-mNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'NPV (95%CI)' |
|---|
| Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 84.1% Precision (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 70.63 to 92.07 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-mNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'PPV (95%CI)' |
|---|
| Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 35.6% Recall (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 27.04 to 45.14 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-mNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'Sensitivity (95%CI)' |
|---|
| Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 61.1% Specificity (patient level; all pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 38.62 to 79.70 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-mNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'Specificity (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 73% Accuracy (patient level; fungal pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 64.46 to 80.04 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'Accuracy (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 71.4% Negative predictive value (patient level; fungal pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 62.46 to 78.98 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'NPV (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 90% Precision (patient level; fungal pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 59.58 to 98.21 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'PPV (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 21.9% Recall (patient level; fungal pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 12.00 to 36.71 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'Sensitivity (95%CI)' |
|---|
| Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026 | Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2) Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026) | 98.8% Specificity (patient level; fungal pneumonia; reference: final clinical diagnosis) percent · higher Uncertainty: 95% CI 93.33 to 99.78 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBlood-bstNGS against the final clinical diagnosis (Huang et al. 2026) dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis Aggregation: Not reported Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'Specificity (95%CI)' |
|---|